DrugEYE™, Data-driven drug discovery
DrugEYE™ provides Pharmaceutical companies, Research laboratories and Health authorities, precious foreknowledge about any emerging organism (virus, bacteria) immediately after it is detected and based on simple input. DrugEYE™ generates its output off-laboratory in a fully data driven way, saving months of wet lab research and funnelling the researcher’s efforts into the right direction.
- Functional characterization of the organism’s genes
- Prediction of the long term impacts on the human body
- Shortlist of candidate molecules to feed the drug discovery
Dynamic customer segmentation
Customer needs and expectations are changing rapidly, and traditional multi-criteria segmentation or clustering methods are no longer sufficient to act on the rapidly changing customer needs. The solutions allows to anticipate on customer needs based on a robust modelling of their behaviour and preferences, giving your company a leap ahead of the competition.
- AI inferred customer segmentation
- Automatic update of the segmentation identifying emerging customer behavioural patterns
- Ongoing recommendation engine for up-selling, cross-selling, Next Best Opportunities, Next Best Actions, best channel
Related news
MajestEYE joins the British Telecom innovation cluster We are happy to share with you that MajestEYE has just been admitted to British Telecom (BT) Incubator, Innovation Martelsham.MajestEYE has just been…
The concept of intuition-driven decision-making is one that has been around since the beginning of time. Groups, clubs, organizations, and companies have operated under the principle that the people at…
Using data analytics to provide businesses with more insights We’re witnessing a rise in the use of big data for analysis across all industries – from healthcare to commerce –…
Digital Transformation is an umbrella term for how businesses adapt their business models to accommodate new technologies like Artificial Intelligence (AI) and big data analytics, enabling them to understand their…
